Pfizer Limited has submitted a regulatory disclosure to BSE Limited and National Stock Exchange of India Ltd regarding a change in senior management personnel.
The company informs that Mr. Sharad Goswami, Senior Director – Policy & Public Affairs, has resigned from the services of the Company. The resignation is effective from September 25, 2026 (close of business). The reason for resignation is to pursue opportunities outside Pfizer Limited.
Mr. Goswami will cease to be a Senior Management Personnel effective September 25, 2026. The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Additional details are provided in Annexure A & Annexure B as required by SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Annexure A provides the following specific details:
- Reason for change: Resignation of Mr. Sharad Goswami, Senior Director – Policy & Public Affairs
- Date of cessation: September 25, 2026 (close of business)
- Brief profile and disclosure of relationships between directors: Not Applicable
The resignation letter from Mr. Sharad Goswami dated September 18, 2026 confirms his resignation effective close of business on September 25, 2026, to pursue opportunities outside Pfizer. The letter is addressed to the Managing Director of Pfizer Limited and expresses thanks to management and colleagues for support during his tenure.
The document is signed by Prajeet Nair, Director – Corporate Services & Company Secretary of Pfizer Limited.
No financial impact or operational consequences of this management change are disclosed in the filing.